AOMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AOMR is not a strong buy right now for a Beginner investor focused on the long term, even with $50,000-$100,000 available. The stock is trading near short-term resistance, has no strong proprietary buy signal today, and insider selling has picked up sharply. While the latest analyst note remains positive, the lowered price target and lack of fresh catalysts keep the setup from being compelling enough to buy immediately. If forced to act now, I would hold rather than buy.
AOMR closed at 9.06, slightly above the previous close of 9.04. The trend is mildly positive but not decisive. MACD histogram is above zero at 0.0687, which is constructive, but it is positively contracting, suggesting momentum is fading. RSI_6 at 67.423 is near overbought territory and shows no clear edge. Moving averages are converging, which points to a sideways-to-mildly bullish setup rather than a strong uptrend. Price is also very close to resistance at R1 9.085 and below R2 9.255, so upside is limited near term.
["BTIG kept a Buy rating on AOMR.", "BTIG views residential credit-focused mREITs as offering more discounted valuation and more book value upside over time.", "Price is holding near the upper end of the recent range."]
["BTIG lowered the price target to $10 from $13.50, which signals reduced upside expectations.", "Insiders are selling, and the selling amount increased 674.81% over the last month.", "No news in the past week, so there is no fresh event-driven catalyst.", "AI Stock Picker shows no signal today.", "SwingMax shows no signal recently.", "Similar candlestick pattern analysis implies weak forward returns over the next week and month."]
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot assess the most recent quarter's revenue, earnings, or dividend-related growth trends with confidence.
Recent analyst sentiment is still constructive, with BTIG maintaining a Buy rating, but the firm cut its price target sharply to $10 from $13.50 on 2026-06-17. That suggests Wall Street still sees upside, but expectations have been scaled back. Pros: Buy rating and continued belief in book value upside for residential credit-focused mREITs. Cons: Reduced target, no fresh positive catalysts, and insider selling make the overall Wall Street view less compelling than before.
